Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum	Skin Ulcer, Skin and Connective Tissue Diseases, injury, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular disease	Recruiting	Phase 2	2026-10-09		NCT07783412

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Incyte Corporation	153
Oregon Health and Science University	244

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Oregon Health & Science University, Department of Dermatology	Portland	United States	2

Clinical trials